No interferon-beta antibodies in natalizumab-treated multiple sclerosis patients with progressive multifocal leukoenceph...
Interferon beta therapy (IFN-β) can induce production of antibodies (NAbs) that may neutralize both therapeutic IFN-β and endogenous IFN-β, potentially impairing antiviral immunity...